Author:
Rajeev Surya Panicker,Sprung Victoria S,Roberts Carl,Harrold Jo A,Halford Jason C G,Stancak Andrej,Boyland Emma J,Kemp Graham J,Cuthbertson Daniel J,Wilding John P H
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of Empagliflozin‐Induced Glycosuria on Weight Gain, Food Intake and Metabolic Indicators in Mice Fed a High‐Fat Diet;Endocrinology, Diabetes & Metabolism;2024-03
2. No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE);Diabetes, Obesity and Metabolism;2023-09-05
3. SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?;Polish Archives of Internal Medicine;2022-09-12
4. The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The
SEESAW
randomized, double‐blind, placebo‐controlled trial;Diabetes, Obesity and Metabolism;2022-05-13
5. Is polypharmacy the future for pharmacological management of obesity?;Current Opinion in Endocrine and Metabolic Research;2022-04